Automated description from the Alliance of Genome Resources (Release 3.2)
Predicted to have R-SMAD binding activity and co-SMAD binding activity. Predicted to be involved in negative regulation of BMP signaling pathway; protein ubiquitination; and regulation of transforming growth factor beta receptor signaling pathway. Localizes to nucleus. Is expressed in genitourinary system and submandibular gland primordium. Orthologous to human TRIM33 (tripartite motif containing 33).